Neuromuscular transmission disorders and other conditions


Spinal Muscular Atrophy Motor Neuron Disease Neonatal Tetanus Stiff Person Syndrome Lambert Eaton Myasthenic Syndrome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. AAEM Quality Assurance Committee (2001) Literature review of the usefulness of repetitive nerve stimulation and single fiber EMG in the electrodiagnostic evaluation of patients with suspected myasthenia gravis or Lambert Eaton myasthenic syndrome. Muscle Nerve 24: 1239–1247Google Scholar
  2. Bromberg MB (2001) Myasthenia gravis and myasthenic syndromes. In: Younger DS (ed) Motor disorders. Williams & Wilkins, Lippincott, Philadelphia, pp 163–178Google Scholar
  3. Evoli A, Minisci C, Di Schino C, et al (2002) Thymoma in patients with MG. Neurology 59: 1844–1850PubMedGoogle Scholar
  4. Grob D, Arsuie EL, Brunner NG, et al (1987) The course of myasthesia and therapies affecting outcome. Ann NY Acad Sci 505: 472–499PubMedGoogle Scholar
  5. Mantegazza R, Beghi E, Pareyson D, et al (1990) A multicenter follow up study of 1152 patients with myasthenia gravis in Italy. J Neurol 237: 339–344CrossRefPubMedGoogle Scholar
  6. Osserman KE (1958) Myasthenia gravis. Grune & Stratton, New YorkGoogle Scholar
  7. Poulas K, Tsibri E, Kokla A, et al (2001) Epidemiology of seropositive myasthenia gravis in Greece. J Neurol Neurosurg Psychiatry 71: 352–356CrossRefPubMedGoogle Scholar
  8. Wolfe GI, Bahron RJ, Fester BM, et al (2002) Randomized, controlled trial of intravenous immunoglobulin in myasthenia gravis. Muscle Nerve 26: 549–552CrossRefPubMedGoogle Scholar
  9. Argov Z, Mastaglia FL (1979) Disorders of neuromuscular transmission caused by drugs. N Engl J Med 301: 409–413PubMedGoogle Scholar
  10. Barrons RW (1997) Drug-induced neuromuscular blockade and myasthenia gravis. Pharmacotherapy 17: 1220–1232PubMedGoogle Scholar
  11. Howard HF (2002) Neurotoxicology of neuromuscular transmission. In:Katirji B, Kaminski HJ, Preston DC, Ruff RL, Shapiro B (eds) Neuromuscular disorders in clinical practice. Butterworth and Heinemann, Boston, pp 964–986Google Scholar
  12. Senanayake N, Roman GC (1992) Disorders of neuromuscular transmission due to natural environmental toxins. J Neurol Sci 107: 1–13CrossRefPubMedGoogle Scholar
  13. Wittbrodt WT (1997) Drugs and myasthenia gravis. An update. Arch Intern Med 157: 499–408CrossRefGoogle Scholar
  14. Mason WP, Graus F, Lang B, et al (1997) Small cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert Eaton myasthenic syndrome. Brain 120: 1279–1300CrossRefPubMedGoogle Scholar
  15. Nakao YK, Motomura M, Fukudome T et al (2002) Seronegative Lambert Eaton myasthenic syndrome. Neurology 59: 1773–1775PubMedGoogle Scholar
  16. Oh SJ (1989) Diverse electrophysiological spectrum of the Lambert Eaton myasthenic syndrome. Muscle Nerve 12: 464–469PubMedGoogle Scholar
  17. O’Neill JH, Murray NMF, Newsom-Davies J (1988) The Lambert Eaton myasthenic syndrome. Brain 111: 577–596PubMedGoogle Scholar
  18. O’suilleabhain P, Low PA, Lennon VA (1998) Autonomic dysfunction in the Lambert-Eaton myasthenic syndrome. Neurology 50: 88–93PubMedGoogle Scholar
  19. Cherington M (1998) Clinical spectrum of botulism. Muscle Nerve 21: 701-10CrossRefPubMedGoogle Scholar
  20. Cherington M (2002) Botulism. In: Katirji B, Kaminski HJ, Preston DC, Ruff RL, Shapiro B (eds) Neuromuscular disorders in clinical practice. Butterworth Heinemann, Boston, pp 942–952Google Scholar
  21. Hiersemenzel LP, Jerman M, Waespe W (2000) Deszendierende Lähmung durch Wundbotulismus. Eine Falldarstellung. Nervenarzt 71: 130–133Google Scholar
  22. Maselli RA, Bakshi N (2000) Botulism. Muscle Nerve 23: 1137–1144CrossRefPubMedGoogle Scholar
  23. Bleck TP, Brauner JS (1997) Tetanus. In: Scheld WM, Whitley RJ, Durack DT (eds) Infections of the central nervous system, 2nd edn. Raven, Philadelphia, pp 629–653Google Scholar
  24. Farrar JJ, et al (2000) Tetanus. J Neurol Neurosurg Psychiatry 69: 292–301CrossRefPubMedGoogle Scholar
  25. Fauveau V, Mamdani M, Steinglass R, et al (1993) Maternal tetanus: magnitude, epidemiology and potential control measures. Int J Gynaecol Obstet 40: 3–12CrossRefPubMedGoogle Scholar
  26. Mastaglia FL (2001) Cervicocranial tetanus presenting with dysphagia: diagnostic value of electrophysiological studies. J Neurol 248: 903–904CrossRefPubMedGoogle Scholar
  27. Orwitz JI, Galetta SL, Teener JW (1997) Bilateral trochlear nerve palsy and downbeat nystagmus in a patient with cephalic tetanus. Neurology 49: 894–895PubMedGoogle Scholar

Copyright information

© Springer-Verlag/Wien 2005

Personalised recommendations